Nanovaccine-Trained immune cells take on lung cancer
NCT ID NCT07239544
First seen Nov 20, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tests a new way to treat non-small cell lung cancer. Doctors take a patient's own immune cells, train them with a special nanovaccine made from the patient's tumor, and then put them back into the body to fight the cancer. The goal is to see if these cells can safely target and attack the tumor. The study involves 50 people who have had surgery for lung cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Soochow university
Suzhou, Jiangsu, 215000, China
Conditions
Explore the condition pages connected to this study.